Despite remarkable advances in the diagnostic and therapeutic modalities for its
management, cytomegalovirus (CMV) remains one of the most important pathogens …

Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …

Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …

Infections with hepatitis E virus (HEV) in solid-organ transplant recipients can lead to chronic
hepatitis. However, the incidence of de novo HEV infections after transplantation and risk for …

Cytomegalovirus infection (CMV) in solid organ transplant recipients is a major clinical
problem. The aim of this study was to evaluate the incidence of CMV infection and its …

Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …

Background Liver transplantation is one of the most effective therapeutic options for patients
with end-stage liver diseases, and gut microbiota is actively involved in potential infections …

Bacterial infections are common complications of solid organ transplantation (SOT). In this
study, we defined the incidence, mortality and in vitro antimicrobial resistance rates of Gram …

Background Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid
organ transplant recipients. Pre‐emptive treatment of patients with CMV viraemia using …

As the most prevalent pathogen among transplant patients, cytomegalovirus (CMV) affects
up to three‐quarters of all solid organ transplant recipients. While we have made great …